On January 27, 2026, OpenAI launched Prism—a free, AI-native workspace designed to help scientists write papers and collaborate on research. Powered by GPT-5.2, OpenAI’s most advanced model for mathematical and scientific reasoning, Prism signals the company’s aggressive push into healthcare and life sciences.
Prism brings drafting, revision, collaboration, and publication preparation into a single cloud-based, LaTeX-native workspace. It aims to replace the separate tools scientists usually rely on—text editors, PDF readers, reference managers, and chatbots.
Key features demonstrated at the press launch:
Whiteboard to publication: Converts rough whiteboard sketches into publication-quality diagrams
Automatic bibliographies: Generates citations by scouring relevant literature
Research Window: Maintains full project context, preventing “memory loss” common in earlier LLMs
LaTeX-native: Built for researchers who write papers with complex math
Pricing & Availability
Prism is free to use with no subscription fees or collaborator limits for individual users. Available immediately for ChatGPT Personal accounts; ChatGPT Business, Enterprise, and Education availability coming later.
The Strategic Context
“I think 2026 will be for AI and science what 2025 was for AI and software development,” said Kevin Weil, OpenAI’s VP for Science.
The launch comes as AI companies increasingly target healthcare and life sciences as their next major growth area. Both OpenAI and Anthropic have unveiled healthcare-focused products in recent weeks.
Prism is built on Crixet, a cloud-based LaTeX platform OpenAI previously acquired—now evolved into a unified product with AI integrated into the core writing process.
Gennaro is the creator of FourWeekMBA, which reached about four million business people, comprising C-level executives, investors, analysts, product managers, and aspiring digital entrepreneurs in 2022 alone | He is also Director of Sales for a high-tech scaleup in the AI Industry | In 2012, Gennaro earned an International MBA with emphasis on Corporate Finance and Business Strategy.
